PubMed

Topical brinzolamide and metabolic acidosis.

Menon GJ, Vernon SA.

Br J Ophthalmol. 2006 Feb;90(2):247-8. No abstract available. PMID: 16424547 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

Michaud JE, Friren B; International Brinzolamide Adjunctive Study Group.

Am J Ophthalmol. 2001 Aug;132(2):235-43.PMID: 11476685 [PubMed - indexed for MEDLINE]Related articles

Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.

Silver LH.

Am J Ophthalmol. 1998 Sep;126(3):400-8.PMID: 9744373 [PubMed - indexed for MEDLINE]Related articles

[Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors]

Herkel U, Pfeiffer N.

Ophthalmologe. 2001 Oct;98(10):929-33. German. PMID: 11699313 [PubMed - indexed for MEDLINE]Related articles

Switching from dorzolamide to brinzolamide: effect on intraocular pressure and patient comfort.

Inoue K, Wada SA, Wakakura M, Inoue J, Tomita G.

Jpn J Ophthalmol. 2006 Jan-Feb;50(1):68-9. No abstract available. PMID: 16453193 [PubMed - indexed for MEDLINE]Related articles

Ocular hypotensive effect and safety of brinzolamide ophthalmic solution in open angle glaucoma patients.

Wang TH, Huang JY, Hung PT, Shieh JW, Chen YF.

J Formos Med Assoc. 2004 May;103(5):369-73.PMID: 15216404 [PubMed - indexed for MEDLINE]Related articles

The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.

March WF, Ochsner KI.

Am J Ophthalmol. 2000 Feb;129(2):136-43.PMID: 10682964 [PubMed - indexed for MEDLINE]Related articles

Brinzolamide--a new topical carbonic anhydrase inhibitor for glaucoma.

[No authors listed]

Med Lett Drugs Ther. 1998 Sep 25;40(1036):95-6. No abstract available. PMID: 9774966 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group.

Sall K.

Surv Ophthalmol. 2000 Jan;44 Suppl 2:S155-62.PMID: 10665518 [PubMed - indexed for MEDLINE]Related articles

Brinzolamide.

Iester M.

Expert Opin Pharmacother. 2008 Mar;9(4):653-62. Review.PMID: 18312166 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.

Kaback M, Scoper SV, Arzeno G, James JE, Hua SY, Salem C, Dickerson JE, Landry TA, Bergamini MV; Brinzolamide 1%/Timolol 0.5% Study Group.

Ophthalmology. 2008 Oct;115(10):1728-34, 1734.e1-2. Epub 2008 Jun 5.PMID: 18538406 [PubMed - indexed for MEDLINE]Related articles

Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.

Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.

J Glaucoma. 2008 Apr-May;17(3):233-7.PMID: 18414111 [PubMed - indexed for MEDLINE]Related articles

Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension.

Tanimura H, Minamoto A, Narai A, Hirayama T, Suzuki M, Mishima HK.

Jpn J Ophthalmol. 2005 Jul-Aug;49(4):332-3. No abstract available. PMID: 16075340 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma.

Holló G, Chiselita D, Petkova N, Cvenkel B, Liehneova I, Izgi B, Berta A, Szaflik J, Turacli E, Stewart WC.

Eur J Ophthalmol. 2006 Nov-Dec;16(6):816-23.PMID: 17191187 [PubMed - indexed for MEDLINE]Related articles

Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group.

Silver LH.

Surv Ophthalmol. 2000 Jan;44 Suppl 2:S141-5.PMID: 10665516 [PubMed - indexed for MEDLINE]Related articles

[Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note]

Gafencu O, Armegioiu M, Ionita M.

Oftalmologia. 1997;41(1):66-8. Romanian. PMID: 9138500 [PubMed - indexed for MEDLINE]Related articles

Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.

Cvetkovic RS, Perry CM.

Drugs Aging. 2003;20(12):919-47. Review.PMID: 14565787 [PubMed - indexed for MEDLINE]Related articles

[Therapy of normal tension glaucoma: effect of brinzolamide on ocular haemodynamics]

Klemm M, Zeitz O, Reuss J, Matthiessen ET, Richard G.

Klin Monbl Augenheilkd. 2003 May;220(5):330-3. German. PMID: 12766822 [PubMed - indexed for MEDLINE]Related articles

Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting.

Barnebey H, Kwok SY.

Clin Ther. 2000 Oct;22(10):1204-12.PMID: 11110231 [PubMed - indexed for MEDLINE]Related articles

Brinzolamide induced reversible corneal decompensation.

Zhao JC, Chen T.

Br J Ophthalmol. 2005 Mar;89(3):389-90. No abstract available. PMID: 15722328 [PubMed - indexed for MEDLINE]Related articlesFree article